Clinical Trial Update: Study of EB-001 in Facial Scar Reduction [Phase 2]

View source ↗

Summary

Phase 2 trial investigating EB-001 for facial scar reduction in Mohs surgery patients has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Scar
• Mohs Surgery Related Scar

Drugs mentioned

• EB-001

Snippet

Sponsor: Bonti, Inc. | Conditions: Mohs Surgery | Phase 2 | Status: COMPLETED | Results posted: 2018-12-14